5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Silk Road Medical's 5-Year ROIIC % for the quarter that ended in Dec. 2023 was -77.54%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Silk Road Medical's 5-Year ROIIC % or its related term are showing as below:
FRA:2OW's 5-Year ROIIC % is ranked worse than 84.61% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: -0.12
vs FRA:2OW: -77.54
Silk Road Medical 5-Year ROIIC % Historical Data
The historical data trend for Silk Road Medical's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Silk Road Medical's 5-Year ROIIC %
For the Medical Devices subindustry, Silk Road Medical's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Silk Road Medical's 5-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Silk Road Medical's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Silk Road Medical's 5-Year ROIIC % falls into.
Silk Road Medical 5-Year ROIIC % Calculation
Silk Road Medical's 5-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:
5-Year ROIIC %
=
5-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
5-Year Incremental Invested Capital**
=
( -54.352 (Dec. 2023) - -18.806 (Dec. 2018) )
/
( 51.258 (Dec. 2023) - 6.2 (Dec. 2018) )
=
-35.546
/
45.058
=
-78.89%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Silk Road Medical (FRA:2OW) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Silk Road Medical 5-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of Silk Road Medical's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy while maintaining a reduction in long-term stroke risk.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:2OW has been successfully added to your 